Q2 FY2026 · ended Jun 30, 2026 · Revenue $1.77M, -0.4% YoY · Filed Aug 14, 2026
InspireMD, Inc. (NSPR) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $1.8 million and a net loss of $14.3 million. Free cash flow was -$11.2 million. As of Jun 30, 2026 it held $30.4 million in cash and investments and $2.0 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- NSPR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miami, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1433607
- Former names
- Saguaro Resources, Inc. (until Apr 1, 2011)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $1.8M | $3.4M | $3.1M | $2.5M | $1.8M |
| Operating income | -$14.4M | -$14.0M | -$12.1M | -$13.1M | -$13.0M |
| Net income | -$14.3M | -$13.7M | -$11.8M | -$12.7M | -$13.2M |
| Diluted EPS | -$0.17 | -$0.16 | -$0.14 | -$0.17 | -$0.26 |
| Operating cash flow | -$10.9M | -$12.3M | -$9.3M | -$8.6M | -$8.3M |
| Free cash flow | -$11.2M | -$12.5M | -$9.7M | -$9.0M | -$8.9M |
| Total assets | $44.6M | $56.5M | $69.4M | $78.5M | $33.3M |
| Total liabilities | $13.1M | $12.9M | $14.2M | $14.4M | $13.1M |
| Stockholders' equity | $31.5M | $43.6M | $55.2M | $64.1M | $20.2M |
| Cash and investments | $30.4M | $41.6M | $54.2M | $63.4M | $19.4M |
| Total debt | $2.0M | $2.0M | $3.3M | $2.4M | $2.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Sep 21, 2026 | Sep 21, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 17, 2026 | Aug 17, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 29, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Listing notice
|
Jul 23, 2026 | Jul 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 2, 2026 | Jun 26, 2026 |
All 1000 InspireMD, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.